These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10576984)

  • 21. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.
    Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T
    J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of post-ERCP pancreatitis.
    Haber GB
    Gastrointest Endosc; 2000 Jan; 51(1):100-3. PubMed ID: 10625814
    [No Abstract]   [Full Text] [Related]  

  • 23. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In patients undergoing precut biliary sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) to facilitate biliary access, is endoscopic pancreatic duct stenting indicated to prevent pancreatitis?].
    Igea Arisqueta F
    Gastroenterol Hepatol; 2009 Mar; 32(3):171-2. PubMed ID: 19231033
    [No Abstract]   [Full Text] [Related]  

  • 25. Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects - A randomized study.
    Zagalsky D; Guidi MA; Curvale C; Lasa J; de Maria J; Ianniccillo H; Hwang HJ; Matano R
    Rev Esp Enferm Dig; 2016 Sep; 108(9):258-562. PubMed ID: 27604474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management.
    Freeman ML
    Gastrointest Endosc Clin N Am; 2012 Jul; 22(3):567-86. PubMed ID: 22748249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of post-endoscopic retrograde cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria.
    Riemann JF
    Dig Liver Dis; 2000; 32(5):419-21. PubMed ID: 11030188
    [No Abstract]   [Full Text] [Related]  

  • 28. Needle-knife sphincterotomy and post-ERCP pancreatitis: time to lower the threshold for the needle?
    Tham TC; Vandervoort J
    Gastrointest Endosc; 2010 Feb; 71(2):272-4. PubMed ID: 20152308
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
    Tarnasky PR; Palesch YY; Cunningham JT; Mauldin PD; Cotton PB; Hawes RH
    Gastroenterology; 1998 Dec; 115(6):1518-24. PubMed ID: 9834280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications of endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy: diagnosis, management and prevention.
    Misra SP; Dwivedi M
    Natl Med J India; 2002; 15(1):27-31. PubMed ID: 11855589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
    Miyatani H; Matsumoto S; Mashima H
    J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
    Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
    Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of ERCP.
    Mallery JS; Baron TH; Dominitz JA; Goldstein JL; Hirota WK; Jacobson BC; Leighton JA; Raddawi HM; Varg JJ; Waring JP; Fanelli RD; Wheeler-Harbough J; Eisen GM; Faigel DO;
    Gastrointest Endosc; 2003 May; 57(6):633-8. PubMed ID: 12709688
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases.
    Hookey LC; RioTinto R; Delhaye M; Baize M; Le Moine O; Devière J
    Endoscopy; 2006 Jul; 38(7):670-6. PubMed ID: 16810591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide and ERCP-induced pancreatitis: beneficial or harmful?
    Binmoeller KB; Harris AG; Hastier P; Dumas R; Delmont JP
    Am J Gastroenterol; 1993 Aug; 88(8):1291. PubMed ID: 8338107
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short term complications of endoscopic retrograde cholangiopancreatography].
    Barthet M; Heyries L; Desjeux A
    Gastroenterol Clin Biol; 2002 Nov; 26(11):980-7. PubMed ID: 12483128
    [No Abstract]   [Full Text] [Related]  

  • 38. ERCP and endoscopic sphincterotomy-induced pancreatitis.
    Sherman S
    Am J Gastroenterol; 1994 Mar; 89(3):303-5. PubMed ID: 8122635
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum toxin injection after biliary sphincterotomy.
    Cotton PB; Hawes RH
    Endoscopy; 2004 Aug; 36(8):744; author reply 745. PubMed ID: 15280987
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse events associated with ERCP.
    ; Chandrasekhara V; Khashab MA; Muthusamy VR; Acosta RD; Agrawal D; Bruining DH; Eloubeidi MA; Fanelli RD; Faulx AL; Gurudu SR; Kothari S; Lightdale JR; Qumseya BJ; Shaukat A; Wang A; Wani SB; Yang J; DeWitt JM
    Gastrointest Endosc; 2017 Jan; 85(1):32-47. PubMed ID: 27546389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.